PlainRecalls
FDA Drug Low Class III Terminated

Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Mint flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10091 3.

Reported: August 28, 2013 Initiated: August 6, 2013 #D-909-2013

Product Description

Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Mint flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10091 3.

Reason for Recall

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Details

Recalling Firm
Novartis Consumer Health
Units Affected
23,856 bottles
Distribution
Nationwide, Canada, and Panama.
Location
Lincoln, NE

Frequently Asked Questions

What product was recalled?
Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Mint flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10091 3.. Recalled by Novartis Consumer Health. Units affected: 23,856 bottles.
Why was this product recalled?
Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 28, 2013. Severity: Low. Recall number: D-909-2013.